HK Stock Market Move | JD HEALTH (06618) rose more than 4% and deepened its strategic cooperation with Jiangsu Yuyue Medical Equipment & Supply in AI medical devices, with a focus on blood glucose management and respiratory health.

JD HEALTH (06618) rose over 4%, as of press time, up 4.39% to 51.15 Hong Kong dollars, with a turnover of 159 million Hong Kong dollars. On the news front, according to JD HEALTH's blackboard report, JD HEALTH and Jiangsu Yuyue Medical Equipment & Supply, a leading domestic medical equipment brand, recently announced a comprehensive strategic cooperation. The heavy official announcement stated that the two parties will jointly anchor a strategic goal of sales scale of 10 billion yuan over three years, aiming to create an industry-level growth benchmark. In this cooperation, both parties are committed to reshaping medical equipment with AI, driving product upgrades with technology, and reconstructing health experiences with ecology, leveraging JD HEALTH's core capabilities in AI technology, digital services, full-chain supply chain, and user operations. Of note, the initial cooperation will focus on two major areas, blood glucose management and respiratory health. In terms of blood glucose management, the two parties will jointly develop AI data analysis and intervention reminder functions based on Yuwell's continuous glucose monitoring system (CGM), creating an intelligent full-cycle management solution for diabetic patients. In the field of respiratory health, the two parties plan to integrate AI algorithms into Yuwell's respiratory machine products to achieve intelligent identification of respiratory events, adaptive adjustment of treatment parameters, and remote monitoring of patient conditions, enhancing user treatment experience and compliance.